Dienogest Synthesis via Birch Reduction and Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing synthetic methods for dienogest, a contraceptive steroid, are inefficient due to high step counts, difficult scalability, and the use of undesirable reagents like cyanide and chromium oxidants.

Innovation Solution

A novel synthesis method starting from estrone-3-methylether, involving steps such as alkylation, partial reduction, cyanomethylation, and bromination, to produce dienogest in high purity, using more accessible and environmentally friendly reagents and conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional synthetic methods are used to obtain dienogest, then the product can be obtained, but the synthesis requires a high number of steps and uses undesirable reagents such as cyanide, chromium oxidants, or cerium

Engineering Contradiction:
Improveproduct purityVSAvoidsynthesis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The synthesis is divided into distinct modular steps: ketal formation, Birch reduction, ketone reformation, cyanomethylation, and dehydrohalogenation. Each step is optimized independently, allowing for better control and reduced overall complexity despite maintaining multiple transformation stages.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces protective groups (ketal formation at C17) and intermediate compounds that facilitate selective transformations. These intermediaries enable complex molecular modifications while maintaining control over reaction specificity and product purity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional synthetic methods are used to obtain dienogest, then the product can be obtained, but the reactions are difficult to increase in scale

Engineering Contradiction:
Improveproduct purityVSAvoidscalability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent optimizes reaction parameters including temperature ranges (-78°C to room temperature), solvent compositions (ether/alcohol mixtures), and stoichiometric ratios to enable scalable production. The Birch reduction conditions and cyanomethylation parameters are specifically tuned for both laboratory and industrial scale operations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The synthesis employs readily available, inexpensive reagents and solvents (lithium, ammonia, ethanol, pyridinium tribromide) that can be easily sourced and handled at scale, replacing expensive or specialized materials used in conventional methods.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If conventional synthetic methods are used to obtain dienogest, then the product can be obtained, but hazardous reagents such as cyanide, chromium oxidants, or cerium are used

Engineering Contradiction:
Improveproduct purityVSAvoidhazardous reagent exposure
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces hazardous reagents with safer alternatives that achieve the same chemical transformations. For example, pyridinium tribromide replaces chromium oxidants, and controlled cyanomethylation using cyanomethyl lithium followed by hydrolysis replaces direct cyanide usage, reducing toxicity while maintaining product purity.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

Protective groups and intermediate compounds are used to enable selective transformations without requiring harsh reagents. The ketal protection at C17 and controlled reduction/oxidation sequences allow for high purity product formation using milder, safer chemical conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Object-affected harmful factors

If a novel synthesis method is developed to avoid hazardous reagents and reduce steps, then safety and simplicity improve, but achieving high purity and yield becomes more challenging

Engineering Contradiction:
Improvehazardous reagent exposureVSAvoidproduct purity
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The patent employs careful monitoring of reaction progress and product characterization at each step, with optimized workup and purification procedures that ensure high purity final product. The systematic approach to each transformation step allows for quality control without requiring hazardous reagents.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces the complexity and cost of dienogest production, achieving high yields and purity while avoiding the use of hazardous reagents, thus providing an economic and efficient route to the steroid.

Implementation Method 1

subjecting the product of step a) to partial reduction by reaction with alkali metal in liquid ammonia to form 3-methoxy-17,17-dialkoxy-estra-2,5(10)-diene

Methodology Applied
Scientific EffectSingle electron transfer (SET): Redox Reactions

Implementation Method 2

treating the product of step d) with oxalic acid

Methodology Applied
Scientific EffectAcid-base reaction: Hydrolysis

Implementation Method 3

treating the product of step e) with pyridinium tribromide in pyridine

Methodology Applied
Scientific EffectElectrophilic aromatic substitution: Chemical Bonding

Data Source

PatentEP2256128B1Method for synthesis of dienogest from estrone-3-methylether
Publication Date: 2011.12.07 HEYL CHEM PHARMA FAB GMBH & CO KG
  • EP2256128B1 patent drawingFigure 1
  • EP2256128B1 patent drawing
  • EP2256128B1 patent drawing

AI summary

The invention concerns a method for the synthesis of dienogest from 3-methoxy-estra-1,3,5-trien-17-one is comprising the steps of a) reacting 3-methoxy-estra-1,3,5-trien-17-one with alcohol in the presence of an acid in an organic solvent to form 3-methoxy-17,17-dialkoxy-estra-1,3,5-triene; b) subjecting the product of step a) to partial reduction by reaction with alkali metal in liquid ammonia; c) treating the product of step b) with mild acid; d) reacting the product of step c) with cyanomethyl lithium; e) treating the product of step d) with oxalic acid and f) treating the product of step e) with pyridinium tribromide in pyridine to yield dienogest.